HOWARD I RUTMAN, MD
Osteopathic Medicine at 210 St, Bronx, NY
License number
New York 150497
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
111 EAST 210Th St, Bronx, NY 10467
401 E 80Th St, New York, NY 10021
401 E 80Th St, New York, NY 10021
Phone
(718) 405-8477
(718) 405-8476 (Fax)
(718) 405-8476 (Fax)
Organization information
See more information about HOWARD I RUTMAN at bizstanding.comHoward I Rutman MD
New York, NY
Industry:
Nonclassifiable Establishments
Addresses:
201 E 77 St, New York, NY 10075
401 E 80 St, New York, NY 10075
401 E 80 St, New York, NY 10075
Medical Doctor:
Howard Rutman (Medical Doctor)
HOWARD I. RUTMAN, M.D., PC
65 E 96 St, New York, NY 10128
Status:
Inactive
Doing business as:
Howard I Rutman MD
Inactive reason:
Dissolution
Registration:
Mar 12, 1997
Inactive since:
Jun 28, 2007
Phone:
(212) 860-8600 (Phone)
State ID:
2122296
Business type:
DOMESTIC PROFESSIONAL CORPORATION
Howard I Rutman, 65 E 96 St, New York, NY 10128 (Physical)
Categories:
Cardiology Physicians & Surgeons, Physicians & Surgeons
Professional information
Group Vice President, Medical Director At Taro Pharmaceuticals
Position:
Group Vice President, Medical Director at Taro Pharmaceuticals, Attending at Mount Sinai School of Medicine, Cardiology Attending at Albert Einstein College of Medicine
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
Taro Pharmaceuticals
since Apr 2003
-
Group Vice President, Medical Director
Mount Sinai School of Medicine
since Jul 1988
-
Attending
Albert Einstein College of Medicine
since Jun 1986
-
Cardiology Attending
Montefiore Hospital
Jul 1986 - Apr 2007
-
Attending
Education:
New York University - Leonard N. Stern School of Business 2000 - 2002
MBA, Management The Johns Hopkins University School of Medicine 1977 - 1981
MD Harvard University 1973 - 1977
AB, Biochemical Sciences
MBA, Management The Johns Hopkins University School of Medicine 1977 - 1981
MD Harvard University 1973 - 1977
AB, Biochemical Sciences
Dr. Howard I Rutman, Bronx NY - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
Division of Cardiology-Montefiore-Einstein
111 E 210Th St, Bronx 10467
(718) 920-5528 (Phone)
65 E 96Th St, New York 10128
(212) 426-7300 (Phone)
111 E 210Th St, Bronx 10467
(718) 920-5528 (Phone)
65 E 96Th St, New York 10128
(212) 426-7300 (Phone)
Conditions:
Arrhythmias (incl. Atrial Fibrillation), Hypertension, Mitral Valve Disease
Certifications:
Cardiovascular Disease, 1987, Internal Medicine, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Division of Cardiology-Montefiore-Einstein
111 E 210Th St, Bronx 10467
65 E 96Th St, New York 10128
Montefiore Medical Center
111 East 210Th St, Bronx 10467
111 E 210Th St, Bronx 10467
65 E 96Th St, New York 10128
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Education:
Medical School
Johns Hopkins University School Of Medicine
Graduated: 1981
Ny Hosp/Cornell Med Center
Graduated: 1984
Einstein
Graduated: 1986
Johns Hopkins University School Of Medicine
Graduated: 1981
Ny Hosp/Cornell Med Center
Graduated: 1984
Einstein
Graduated: 1986
Topical Gel Formulation Comprising Organophosphate Insecticide And Preparation Thereof
US Patent:
8012498, Sep 6, 2011
Filed:
Jul 12, 2005
Appl. No.:
11/179719
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NY, US
International Classification:
A01N 57/10, A01N 57/12, A61K 9/06, A61K 31/661, A61K 47/38, A61P 33/14
US Classification:
424405, 424407, 514122, 514781
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0. 1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.
Topical Gel Formulation Comprising Organophosphate Insecticide And Preparation Thereof
US Patent:
2012005, Mar 1, 2012
Filed:
Aug 30, 2011
Appl. No.:
13/220935
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Assignee:
Taro Pharmaceuticals North America, Inc. - Grand Cayman
International Classification:
A61K 31/6615, A61P 33/14
US Classification:
514122
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.
Topical Gel Formulation Comprising Organophosphate Insecticide And Preparation Thereof
US Patent:
8158139, Apr 17, 2012
Filed:
Feb 9, 2006
Appl. No.:
11/351188
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Latchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Latchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Assignee:
Taro Pharmaceuticals North America, Inc. - Grand Cayman
International Classification:
A01N 57/10, A01N 57/12, A01N 25/02, A61K 9/08, A61K 31/661, A61K 47/10, A61K 47/14, A61P 33/14
US Classification:
424405, 514122, 514786
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0. 1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present topical formulations encompass a non-flammable solvent for malathion effective in killing head lice. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.
Composition And Method For Improved Bioavailability And Enhanced Brain Delivery Of 5,5-Diphenyl Barbituric Acid
US Patent:
8076346, Dec 13, 2011
Filed:
Jan 19, 2010
Appl. No.:
12/689757
Inventors:
Daniella Gutman - Rishon Lezion, IL
Barrie Levitt - Mamaroneck NY, US
Daniel A. Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
Barrie Levitt - Mamaroneck NY, US
Daniel A. Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
Assignee:
Taro Pharamaceutical Industries Ltd. - Haifa Bay
International Classification:
A61K 31/515, C07D 239/64
US Classification:
514270, 544305
Abstract:
The present invention relates to a composition and a method of delivering a barbituric acid derivative to the central nervous system of a mammal in need of treatment for neurological conditions. In particular, the present invention relates to a method of administering an oral dosage form of a sodium salt of 5,5-diphenyl barbituric acid to enhance the bioavailability of 5,5-diphenyl barbituric acid and brain delivery of same.
Composition And Method For Improved Bioavailability And Enhanced Brain Delivery Of 5,5-Diphenyl Barbituric Acid
US Patent:
2006012, Jun 8, 2006
Filed:
Aug 10, 2005
Appl. No.:
11/201024
Inventors:
Daniella Gutman - Rishon Lezion, IL
Daniel Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
Daniel Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
International Classification:
A61K 31/515
US Classification:
514270000
Abstract:
The present invention relates to a composition and a method of delivering a barbituric acid derivative to the central nervous system of a mammal in need of treatment for neurological conditions. In particular, the present invention relates to a method of administering an oral dosage form of a sodium salt of 5,5-diphenyl barbituric acid to enhance the bioavailability of 5,5-diphenyl barbituric acid and brain delivery of same.
Topical Gel Formulation Comprising Insecticide And Its Preparation Thereof
US Patent:
2006012, Jun 8, 2006
Filed:
Jul 12, 2005
Appl. No.:
11/179924
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundus - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Subhas Kundus - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
International Classification:
A01N 65/00, A01N 25/00, A01N 43/04, A01N 55/00, A01N 43/30, A01N 29/04
US Classification:
424405000, 514028000, 514065000, 514063000, 514464000, 514747000
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.